News & Views

  • Partnership to Help Accelerate Clinical Trials in Japan

Partnership to Help Accelerate Clinical Trials in Japan

Oct 23 2017 Read 314 Times

Parexel a global biopharmaceutical services provider and Osaka International Cancer Institute have formed an alliance to advance clinical development in Japan. The partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and haematology, accelerating the development of innovative and effective new cancer treatments for patients.

“Oncology continues to be the largest therapeutic area in clinical trials today,and is a priority for Parexel as we partner with clients to deliver new therapies to patients in need,” said Shogo Nakamori, Corporate Vice President, Clinical Research Services, Asia Pacific, Parexel. “Osaka International Cancer Institute is a centre of excellence for clinical trials in the Kansai region of Japan. Through this alliance, Parexel and the Osaka International Cancer Institute will work to drive greater efficiencies for local and global biopharmaceutical companies, helping them accelerate the clinical development of innovative and effective new treatments in this difficult disease area.”

“The advancement of clinical trials in oncology is imperative in the development of promising new therapies for patients in Japan and around the world,” said Dr. Nariaki Matsuura, President of Osaka International Cancer Institute. “We are pleased to be working with Parexel, an innovative partner with a large presence in Japan,and globally, with leading clinical and scientific expertise in oncology. Through this collaboration, Osaka International Cancer Institute will gain access to novel treatments sooner, providing a wider range of potential treatment options for our patients and allowing us to make a strong contribution to the further advancement of cancer treatments.”

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Lab Asia December 2018

December 2018

In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...

View all digital editions

Events

Smart Factory Expo (SFE 2019)

Jan 16 2019 Tokyo, Japan

Arab Health

Jan 28 2019 Dubai International Convention & Exhibition Centre

Nano Tech 2019

Jan 30 2019 Tokyo, Japan

World Congress on Chromatography

Jan 31 2019 Paris, France

View all events